CompletedPhase 3

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

United States1,875 participantsStarted 2011-10

Plain-language summary

The purpose of this study is to assess whether glycemic control (assessed with HbA1c measurement) in individuals with type 1 or type 2 diabetes can be improved with a point-of-care measurement of HbA1c in the ophthalmologist's office combined with a personalized risk assessment for diabetic retinopathy and other complications of diabetes.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age \>18 years
✓. Diagnosis of type 1 or type 2 diabetes mellitus
✓. Routine care follow-up is yearly or more frequent
✓. English or Spanish speaking
✓. Able and willing to provide informed consent
✓. Willing to complete 24 months of study follow up

Exclusion criteria

✕. Known HbA1c (patient report or available records at time of enrollment) \<7.5% within prior 6 months
✕. Active participation in any type of intervention study
✕. Initiation of insulin treatment within 3 months from date of enrollment
✕. Prior complete panretinal photocoagulation or prior diabetes-related vitrectomy in both eyes
✕. Advanced visual acuity loss in both eyes which prohibits ability to read study materials (tested as needed with reading test using materials in appropriate size script)
✕. Significant renal disease including use of erythropoietin (Procrit, Epogen, Eprex) or a history of chronic renal failure requiring dialysis or kidney transplant

What they're measuring

Change in HbA1c

Timeframe: 12 Months

Trial details

NCT IDNCT01323348

SponsorJaeb Center for Health Research

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-07

View on ClinicalTrials.gov More Diabetes trials